Fresh analysis suggests that patients who discontinue new GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end conventional lifestyle regimens.
Findings released in a prominent medical journal points out that while obese people often shed a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month after stopping.
"People buying these treatments should be aware of the potential of fast weight regain when the medication is stopped," warns researcher Dr. Susan Jebb.
That rate of recovery suggests a return to original mass in about 18 months.
Comparing Treatments
The analysis, which reviewed dozens of studies involving thousands of participants, contrasted the results of the injectable medications with conventional dieting.
Researchers note that individuals who shed pounds through dieting usually experience a more gradual creep back—approximately 100 grams monthly—after stopping.
Explaining the Rapid Regain
Nutrition scientists believe the mechanism of the jabs accounts for the amplified rebound.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making binge eating far more likely."
A Lifelong Disease?
The NHS suggest the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts contend that, due to the likelihood of relapse, the therapy should be considered life-long.
This opinion is echoed by drug manufacturers, who say that the findings "underscore the persistent character of obesity," similar to managing diseases like high blood pressure.
User Testimonies
Individuals who have come off the jabs report a intense resurgence of hunger.
"I experienced a trigger activating and you become ravenous," described an individual.
This challenge is exacerbated if individuals have not developed lasting dietary or behavioural changes during treatment.
Significant Use
Recent estimates show that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is more common among women compared to males.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a magic fix and lasting health benefits likely depends on ongoing behavioural support.
